Microbes and asthma: The missing cellular and molecular links

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 1, 2012, Pages 14-22

  Brar, Tina ^a   Nagaraj, Srinivas ^a   Mohapatra, Shyam ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

asthma; elderly; eosinophil; microbe; microbiota

Indexed keywords

ALLERGEN; ANTIBODY; CHEMOKINE; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; HEPARIN; HISTAMINE; INFLAMMASOME; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; LEUKOTRIENE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROSTAGLANDIN; PROTEINASE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ADENOVIRUS; ALLERGIC ASTHMA; ALTERNARIA; ASPERGILLUS; ASTHMA; BACTERIAL INFECTION; BACTERIUM; BARTONELLACEAE; BOCAVIRUS; BONE MARROW CELL; BRONCHUS HYPERREACTIVITY; BRONCHUS OBSTRUCTION; CAULOBACTERACEAE; CD4+ T LYMPHOCYTE; CHLAMYDOPHILA PNEUMONIAE; CLADOSPORIUM; COMAMONADACEAE; CORONAVIRUS; CORYNEBACTERIUM; DISEASE EXACERBATION; ENTEROBACTERIACEAE; ENTEROVIRUS; ENVIRONMENTAL FACTOR; EOSINOPHIL; GENETIC PREDISPOSITION; GROUPS BY AGE; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HELICOBACTER PYLORI; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN RHINOVIRUS; INFECTION; INFLUENZA VIRUS; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; MICROBIAL DIVERSITY; MICROBIOME; MICROORGANISM; MOLECULAR DYNAMICS; MORAXELLA CATARRHALIS; MUCUS SECRETION; MYCOPLASMA PNEUMONIAE; MYELOID DERIVED SUPPRESSOR CELL; NEISSERIA; NEUTROPHIL; NITROSOMONADACEAE; NONHUMAN; ORTHOMYXOVIRUS; PARAINFLUENZA VIRUS; PARAMYXOVIRUS; PATHOGENESIS; PENICILLIUM; PICORNAVIRUS; PROPIONIBACTERIUM; PROTEOBACTERIA; RALSTONIA; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFLAMMATION; REVIEW; SHEWANELLACEAE; SPHINGOMONADACEAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; SUPPRESSOR CELL; UREAPLASMA UREALYTICUM;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CORYNEBACTERIUM INFECTIONS; FEMALE; HUMANS; INFANT; INTERLEUKIN-1; INTERLEUKIN-6; MALE; METAGENOME; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83155173906     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834dccc0     Document Type: Review

References (50)

1. Umetsu DT, DeKruyff RH. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: microbes, apoptosis and TIM-1 in the development of asthma. Clin Exp Immunol 2010; 160:125-129.
2. Health Data Interactive. (HDI). CDC. National Center for Health Statistics. www.cdc.gov/nchs/hdi.html [accessed July 2011].
3. Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009; 46:73-80.
4. Tzortzaki EG, Proklou A, Siafakas NM. Asthma in the elderly: can we distinguish it from COPD? J Allergy 2011; 2011:843543.
5. Jartti L, Langen H, Soderlund-Venermo M, et al. New respiratory viruses and the elderly. Open Respir Med J 2011; 5:61-69.
6. Chung HL. Asthma in childhood: a complex, heterogeneous disease. Korean J Pediatr 2011; 54:1-5.
7. Fujitsuka A, Tsukagoshi H, Arakawa M, et al. A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness. BMC Infect Dis 2011; 11:168.
8. Reynolds HY. Modulating airway defenses against microbes. Curr Opin Pulm Med 2002; 8:154-165. (Pubitemid 34408994)
9. Kusel MM, de Klerk NH, Kebadze T, et al. Early life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105-1110. (Pubitemid 46654175)
10. Kumar RK, Hitchins MP, Foster PS. Epigenetic changes in childhood asthma. Dis Models Mech 2009; 2:549-553.
11. Vale-Pereira S, Todo-Bom A, Geraldes L, et al. FoxP3, GATA-3 and T-bet expression in elderly asthma. Clin Exp Allergy 2011; 41:490-496.
12. Reed CE. Asthma in the elderly: diagnosis and management. J Allergy Clin Immunol 2010; 126:681-687.
13. Arnold IC, Dehzad N, Reuter S, et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011; 121:3088-3093.
14. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 2009; 7:887-894.
15. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; doi: 10.1164/rccm.201104-0655OC [Epub ahead of print].
16. Kloepfer KM, Gern JE. Virus/allergen interactions and exacerbations of asthma. Immunol Allergy Clin N Am 2010; 30:553-563.
17. McErlean P, Greiman A, Favoreto S, et al. Viral diversity in asthma. Immunol Allergy Clin N Am 2010; 30:481-495.
18. Bisgaard H, Hermansen M, Bønnelykke K, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective nested birth cohort study. BMJ 2010; 341:c4978.
19. De Paula NT, Carneiro BM, Yokosawa J, et al. Human rhinovirus in the lower respiratory tract infections of young children and the possible involvement of a secondary respiratory viral agent. Mem Inst Oswaldo Cruz 2011; 106:316-321.
20. Lemon KP, Klepac-Ceraj V, Schiffer HK, et al. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. MBio 2010; 1:e00129-10.
21. Huffnagle GB. The microbiota and allergies/asthma. PLoS Pathog 2010; 6:e1000549.
22. Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-381.
23. Biswas D, Agarwal S, Sidhwani G, Rawat J. Fungal colonization in patients with chronic respiratory diseases from Himalayan region of India. Ann Clin Microbiol Antimicrob 2010; 9:28.
24. Pongracic JA, O'Connor GT, Muilenberg ML, et al. Differential effects of outdoor versus indoor fungal spores on asthma morbidity in inner-city children. J Allergy Clin Immunol 2010; 125:593-599.
25. Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerg Infect Dis 2006; 12:217-223.
26. Scotta C, Bennasar A, Moore ER, et al. Taxonomic characterisation of ceftazadime-resistant Brevundimonas isolates and description of Brevundimonas faecalis sp. nov. Syst Appl Microbiol 2011; 34:408-413.
27. Han XY, Andrade RA. Brevundimonas diminuta infections and its resistance to fluroquinolones. J Antimicrob Chemother 2005; 55:853-859. (Pubitemid 40883167)
28. Tsui TL, Tsao SM, Liu KS, et al. Comamonas testosteroni infection in Taiwan: reported two cases and literature review. J Microbiol Immunl Infect 2011; 44:67-71.
29. Bollet C, Gainnier M, Sainty JM, et al. Serratia fonticola isolated from a leg abscess. J Clin Microbiol 1991; 29:834-835.
30. Samonis G, Vouloumanou EK, Christofaki M, et al. Serratia infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 2011; 30:653-660.
31. Stein LY, Arp DJ, Berube PM, et al. Whole-genome analysis of the ammoniaoxidizing bacterium, Nitrosomonas eutropha C91: implications for niche adaptation. Environ Microbiol 2007; 9:2993-3007. (Pubitemid 350076288)
32. Chain P, Lamerdin J, Larimer F, et al. Complete genome sequence of the ammonia-oxidizing bacterium and obligate chemolithoautotroph Nitrosomonas europaea. J Bacteriol 2003; 185:2759-2773. (Pubitemid 36514587)
33. Vandamme P, Goris J, Coenye T, et al. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov. Int J Syst Bacteriol 1999; 49 (Pt 2):663-669.
34. Hau HH, Gralnick JA. Ecology and biotechnology of the genus Shewanella. Annu Rev Microbiol 2007; 61:237-258. (Pubitemid 350058208)
35. Toh HS, Tay HT, Kuar WK, et al. Risk factors associated with Sphingomonas paucimobilis infection. J Microbiol Immunol Infect 2011; 44:289-295.
36. Yao TC, Chang CJ, Hsu YH, Huang JL. Probiotics for allergic diseases: realities and myths. Pediatr Allergy Immunol 2010; 21:900-919.
37. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol 2011; 12:5-9.
38. Vael C, Vanheirstraeten L, Desager KN, Goossens H. Denaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma. BMC Microbiol 2011; 11:68.
39. Michail S. The role of probiotics in allergic diseases. Allergy Asthma Clin Immunol 2009; 5:5.
40. Madore AM, Laprise C. Immunological and genetic aspects of asthma and allergy. J Asthma Allergy 2010; 3:107-121.
41. Callaway Z, Kim CK. Respiratory viruses, eosinophilia and their roles in childhood asthma. Int Arch Allergy Immunol 2011; 155:1-11.
42. Sly PD. The early origins of asthma: who is really at risk? Curr Opin Allergy Clin Immunol 2011; 11:24-28.
43. Nabe T, Hosokawa F, Matsuya K, et al. Important role of neutrophils in the late asthmatic response in mice. Life Sci 2011; 88:1127-1135.
44. Woodfin A, Voisin MB, Beyrau M, et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol 2011; 12:761-769.
45. Hartlova A, Krocova Z, Cerveny L, Stulik J. A proteomic view of the hostpathogen interaction: the host perspective. Proteomics 2011; 11:3212-3220.
46. Takeuchi O, Akira S. Recognition of viruses by innate immunity. Immunol Rev 2007; 220:214-224. (Pubitemid 350045565)
47. Yano T, Kurata S. Intracellular recognition of pathogens and autophagy as an innate immune host defence. J Biochem 2011; 150:143-149.
48. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388:621-625.
49. Barton GM. A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008; 118:413-420. (Pubitemid 351206528)
50. Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev 2009; 227:221-233.